多参数静态混合¹⁸F-FET PET/MR术前预测胶质母细胞瘤TERT启动子突变
本研究回顾性纳入220例新诊断胶质母细胞瘤患者,探讨多参数¹⁸F-FET PET/MRI非侵入性预测TERT启动子突变的价值。多变量分析显示年龄、TBRmax和nADCmax为独立预测因子,联合临床与影像变量的模型AUC达0.893,敏感度84.3%,特异度89.4%,优于单独临床或影像模型。
要点
- 年龄、TBRmax和nADCmax是TERT启动子突变的独立预测因子。
- 联合临床与影像参数的模型预测效能最高,AUC为0.893。
- ¹⁸F-FET PET/MRI多参数定量分析有助于术前无创分层。
关键影像表现/征象
- 在FLAIR图像上勾画肿瘤感兴趣区并转移至配准的¹⁸F-FET PET、CBF和ADC参数图进行定量分析。
- 以对侧正常白质为参考区计算nADC和nCBF(肿瘤/正常比值),PET摄取以肿瘤/脑比值(TBR)表示。
诊断标准与关键数值
- 多变量logistic回归显示年龄(OR 1.088,95%CI 1.030-1.148;P=0.002)、TBRmax(OR 2.586,95%CI 1.126-6.015;P=0.033)和nADCmax(OR 0.130,95%CI 0.024-0.700;P=0.018)为TERT启动子突变的独立预测因子。
- 联合临床与影像变量模型AUC=0.893,敏感度84.3%,特异度89.4%,优于临床模型(AUC=0.749)和影像模型(AUC=0.786)。
临床应用与阅片要点
- 日常阅片可关注¹⁸F-FET PET的TBRmax、ADC的nADCmax及患者年龄,综合评估TERT启动子突变风险。
- 多参数定量分析需在FLAIR图像上准确勾画肿瘤VOI并配准至参数图,注意参考区选择对nADC和nCBF的影响。
局限性
- 本研究为单中心回顾性设计,结论需多中心前瞻性验证。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
PURPOSES: To determine whether multiparametric hybrid 18F-FET PET/MRI enables noninvasive prediction of telomerase reverse transcriptase (TERT) promoter mutation in glioblastoma and to assess the incremental value of combined clinical and imaging parameters.
METHODS: We retrospectively included 220 patients with newly diagnosed glioblastoma at our institution between June 2021 and December 2025. Parametric maps, including ¹⁸F-FET PET, cerebral blood flow (CBF), and apparent diffusion coefficient (ADC), were co-registered with fluid-attenuated inversion recovery (FLAIR) images. Tumor volumes of interest (VOIs) were delineated on FLAIR and transferred to aligned maps for quantitative analysis. Contralateral normal white matter served as the reference region to calculate normalized ADC and CBF values (nADC and nCBF), defined as tumor-to-normal ratios, while PET uptake was expressed as a tumor-to-brain ratio (TBR). Independent predictors were identified using multivariable logistic regression. Diagnostic performance was evaluated using receiver operating characteristic (ROC) analysis with calculation of the area under the curve (AUC).
RESULTS: In multivariable logistic regression analysis, age (OR 1.088, 95% CI 1.030-1.148; P = 0.002), TBRmax (OR 2.586, 95% CI 1.126-6.015; P = 0.033), and nADCmax (OR 0.130, 95% CI 0.024-0.700; P = 0.018) were independent predictors of TERT promoter mutations. The combined model incorporating clinical and imaging variables achieved the highest discriminative performance (AUC = 0.893), with a sensitivity of 84.3% and a specificity of 89.4%, outperforming the clinical-only model (AUC = 0.749) and the imaging-only model (AUC = 0.786).
CONCLUSION: Combining age with multiparametric 18F-FET PET/MRI improves prediction of TERT promoter mutations in glioblastoma and may enable noninvasive preoperative stratification.
引用
- Liang X, Wang L, Xiao K, et al. Multiparametric static hybrid ¹⁸F-FET PET/MR for preoperative prediction of TERT promoter mutation in glioblastoma. Neuroradiology. 2026. PMID: 42714568. doi:10.1007/s00234-026-04077-7
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。